258 related articles for article (PubMed ID: 26948375)
1. Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients.
Heinemann K; Wilde B; Hoerning A; Tebbe B; Kribben A; Witzke O; Dolff S
Scand J Rheumatol; 2016 Jul; 45(4):312-6. PubMed ID: 26948375
[TBL] [Abstract][Full Text] [Related]
2. Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major.
Zahran AM; Elsayh KI; Saad K; Embaby M; Ali AM
Blood Cells Mol Dis; 2016 Mar; 57():91-6. PubMed ID: 26852663
[TBL] [Abstract][Full Text] [Related]
3. Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus.
Zhu HQ; Xu RC; Chen YY; Yuan HJ; Cao H; Zhao XQ; Zheng J; Wang Y; Pan M
Br J Dermatol; 2015 Jan; 172(1):101-10. PubMed ID: 24935080
[TBL] [Abstract][Full Text] [Related]
4. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
[TBL] [Abstract][Full Text] [Related]
5. Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis.
Mavropoulos A; Simopoulou T; Varna A; Liaskos C; Katsiari CG; Bogdanos DP; Sakkas LI
Arthritis Rheumatol; 2016 Feb; 68(2):494-504. PubMed ID: 26414243
[TBL] [Abstract][Full Text] [Related]
6. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
7. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
8. Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides.
Akatsuka T; Miyagaki T; Nakajima R; Kamijo H; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
Eur J Dermatol; 2018 Jun; 28(3):314-319. PubMed ID: 29952298
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
[TBL] [Abstract][Full Text] [Related]
10. The role of CD19+ CD24high CD38high and CD19+ CD24high CD27+ regulatory B cells in patients with type 1 autoimmune pancreatitis.
Sumimoto K; Uchida K; Kusuda T; Mitsuyama T; Sakaguchi Y; Fukui T; Matsushita M; Takaoka M; Nishio A; Okazaki K
Pancreatology; 2014; 14(3):193-200. PubMed ID: 24854615
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of regulatory B10 cells in patients with rheumatoid arthritis with different disease status.
Zheng Z; Li X; Li X; Ding J; Feng Y; Miao J; Luo X; Wu Z; Zhu P
Mol Med Rep; 2015 Sep; 12(3):4584-4591. PubMed ID: 26081876
[TBL] [Abstract][Full Text] [Related]
12. Frequency of CD19
Zhao Q; Jung LK
Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
[TBL] [Abstract][Full Text] [Related]
13. Decreased number of CD19
Li T; Yu Z; Qu Z; Zhang N; Crew R; Jiang Y
Mol Immunol; 2019 Aug; 112():233-239. PubMed ID: 31181422
[TBL] [Abstract][Full Text] [Related]
14. CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer.
Wang WW; Yuan XL; Chen H; Xie GH; Ma YH; Zheng YX; Zhou YL; Shen LS
Oncotarget; 2015 Oct; 6(32):33486-99. PubMed ID: 26378021
[TBL] [Abstract][Full Text] [Related]
15. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
[TBL] [Abstract][Full Text] [Related]
16. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis.
Kim Y; Kim G; Shin HJ; Hyun JW; Kim SH; Lee E; Kim HJ
J Neuroinflammation; 2018 Oct; 15(1):300. PubMed ID: 30373595
[TBL] [Abstract][Full Text] [Related]
17. Purification and immunophenotypic characterization of human B cells with regulatory functions.
de Masson A; Le Buanec H; Bouaziz JD
Methods Mol Biol; 2014; 1190():45-52. PubMed ID: 25015272
[TBL] [Abstract][Full Text] [Related]
18. Loss of Gαq impairs regulatory B-cell function.
He Y; Yuan X; Li Y; Zhong C; Liu Y; Qian H; Xuan J; Duan L; Shi G
Arthritis Res Ther; 2018 Aug; 20(1):186. PubMed ID: 30143054
[TBL] [Abstract][Full Text] [Related]
19. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.
Lepse N; Abdulahad WH; Rutgers A; Kallenberg CG; Stegeman CA; Heeringa P
Rheumatology (Oxford); 2014 Sep; 53(9):1683-92. PubMed ID: 24729403
[TBL] [Abstract][Full Text] [Related]
20. Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma.
Bartosińska J; Purkot J; Karczmarczyk A; Chojnacki M; Zaleska J; Własiuk P; Grząśko N; Morawska M; Walter-Croneck A; Usnarska-Zubkiewicz L; Zielińska P; Jamroziak K; Kowal M; Krasowska D; Chodorowska G; Giannopoulos K
Cells; 2021 Feb; 10(2):. PubMed ID: 33669402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
